Greenway (GWAY) Swings to Q2 Profit
Tweet
Share
E-mailGet Alerts GWAY Hot Sheet
Price: $20.35 --0%
Financial Fact:
Net loss per common share - basic and diluted: -2.53
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net loss per common share - basic and diluted: -2.53
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Greenway Medical Technologies (NYSE: GWAY) reported Q2 EPS of $1.70, versus ($1.01) reported last year. Revenue for the quarter came in at $29.1 million, versus $22.3 million reported last year.
Pro-forma net loss was 1 cent per share.
For earnings history and earnings-related data on Greenway Medical Technologies (GWAY) click here.
Pro-forma net loss was 1 cent per share.
For earnings history and earnings-related data on Greenway Medical Technologies (GWAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Benchmark Reiterates Buy Rating on Jumia Technologies (JMIA)
- Omega Flex (OFLX) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
